Activity Coaching During Pelvic Radiation Therapy
ACTIVATE
ACTIVATE: A Pilot Randomized Activity Coaching Trial to Increase Vitality and Energy During Post-operative Pelvic Radiation Therapy for Endometrial Cancer
1 other identifier
interventional
16
1 country
4
Brief Summary
Research has shown that for women who are undergoing pelvic radiation therapy, fatigue is a common side effect. Fatigue that occurs during radiation therapy can make it harder to perform daily living activities. While there are studies that recommend exercise as a treatment for fatigue in cancer patients and survivors, there are currently no studies that focus on the role of exercise for women undergoing pelvic radiation therapy. The purpose of this study is to see if incorporating an activity coaching program is helpful in improving treatment-related fatigue for women undergoing pelvic radiation therapy for endometrial cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2024
CompletedFirst Posted
Study publicly available on registry
December 24, 2024
CompletedStudy Start
First participant enrolled
January 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
March 3, 2026
March 1, 2026
1.4 years
December 17, 2024
March 2, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility of a Randomized Trial: Participant Adherence to Exercise Coaching Sessions
Participant adherence to coaching sessions will be defined as complete adherence when engaging in 10 of the 10 planned exercise coaching sessions and high adherence as engaging in at least 7 of the planned 10 exercise coach check-ins. Participant adherence will be considered feasible if 70% of participants adhere to the coaching sessions.
Enrollment to end of follow up, up to 24 months
Secondary Outcomes (7)
Change in patient-reported fatigue
Enrollment to end of follow up, up to 24 months
Change in patient-reported bowel/urinary toxicity
Enrollment to end of follow up, up to 24 months
Change in patient-reported Quality of Life (QOL)
Enrollment to end of follow up, up to 24 months
Change in patient-reported cognitive function
Enrollment to end of follow up, up to 24 months
Change in patient-reported sexual function and satisfaction
Enrollment to end of follow up, up to 24 months
- +2 more secondary outcomes
Study Arms (2)
Immediate Start Group
EXPERIMENTALParticipants in this group will start the intervention during the first week of radiation therapy and continue through and post-completion of radiation
Delayed Start Group
EXPERIMENTALParticipants in this group will start 6-8 weeks post - radiation and continue 16-19 weeks post-radiation.
Interventions
An exercise coaching program tailored for women with Stage I-IVA endometrial cancer who have undergone total or modified radical hysterectomy with surgical staging. The intervention targets a total of 8 participants who are planned to complete pelvic external beam radiation therapy as part of their adjuvant treatment.
Eligibility Criteria
You may qualify if:
- At least 18 years of age
- Pathologic diagnosis of endometrial cancer (any histology, Stage I-IVA)
- Has undergone modified radical or radical hysterectomy
- Plan to receive adjuvant treatment with pelvic external beam radiation therapy at ISCI
- ECOG performance status of 0-1
- Patient has a computer, smart phone, or tablet virtual access to the web-based platform and email
- Able to read, understand and provide written informed consent
- Deemed appropriate for unmonitored exercise by treating physician based on the following evidence-based criteria (1)
- Walk without any assistance or assistance device
- Absence of significant cognitive impairment
- Absence of high risk for falls
- Participant does not need to refrain from any activity
You may not qualify if:
- Unable to schedule and attend coaching visits
- Participation in a regular exercise program of ≥150 minutes of moderate intensity exercise a week at baseline
- Unable to perform the five-times stand test
- Medical comorbidities including:
- Unstable angina
- Uncontrolled dysrhythmias
- Acute pulmonary embolus
- Active pulmonary infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Inova Schar Cancer Institute - Alexandria
Alexandria, Virginia, 22311, United States
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
Inova Schar Cancer Institute - Fair Oaks
Fairfax, Virginia, 22033, United States
Inova Schar Cancer Institute - Loudoun
Leesburg, Virginia, 20176, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Avani Rao, MD
Inova Health Care Services
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2024
First Posted
December 24, 2024
Study Start
January 27, 2025
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
March 3, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share